AMSA S.p.A. (CFM Group)
Is this your company? Claim this profile
Drug Product
Company Overview
About
AMSA S.p.A. (CFM Group) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Biologics Manufacturing, Monoclonal Antibodies, Vaccines
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:Italy
Founded:2011
Employees:2,589
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
BSL-2 (Biosafety Level 2)
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
Europe
Regulatory Approvals
Drug Approval SSN83D
FDA · #APR-S1YG3AVA · 2019-12-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-C00ZT9TH
Issued: 2020-12-18
Expires: 2025-07-28
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-STQSINQD
Issued: 2020-08-15
Expires: 2025-09-07
Health Canada GMP
Health Canada
Cert #: CERT-BMTJP4OS
Issued: 2020-11-08
Expires: 2025-09-06
Loading CDMO intelligence...
Key facts about AMSA S.p.A. (CFM Group)
- AMSA S.p.A. (CFM Group) is headquartered in Italy.
- AMSA S.p.A. (CFM Group) was founded in 2011.
- AMSA S.p.A. (CFM Group) has 2,589 employees.
- AMSA S.p.A. (CFM Group)'s capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like AMSA S.p.A. (CFM Group)
Directory pages this company appears in, each with the full list of matching manufacturers.